Home > Qtrly Results > VENUS REMEDIES

VENUS REMEDIES
Quarterly Results Analysis [Mar2025]

VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹195 Cr ₹177 Cr ₹167 Cr ₹109 Cr ₹195 Cr ₹143 Cr ₹168 Cr ₹95 Cr
Expenses ₹166 Cr ₹159 Cr ₹163 Cr ₹97 Cr ₹176 Cr ₹131 Cr ₹150 Cr ₹85 Cr
Operating Income ₹29 Cr ₹18 Cr ₹5 Cr ₹11 Cr ₹19 Cr ₹12 Cr ₹18 Cr ₹10 Cr
Other Income ₹7 Cr ₹2 Cr ₹11 Cr ₹2 Cr ₹4 Cr ₹2 Cr ₹3 Cr ₹2 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹5 Cr ₹5 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹7 Cr ₹6 Cr ₹8 Cr
Profit Before Tax ₹31 Cr ₹25 Cr ₹9 Cr ₹7 Cr ₹17 Cr ₹8 Cr ₹14 Cr ₹5 Cr
Profit After Tax ₹21 Cr ₹20 Cr ₹4 Cr ₹1 Cr ₹11 Cr ₹7 Cr ₹10 Cr ₹1 Cr
EPS ₹15.71 ₹14.66 ₹2.63 ₹0.91 ₹7.86 ₹5.12 ₹7.43 ₹0.88
Industry Peers & Returns1W1M1Y
VENUS REMEDIES -4.1% 46.9% 41.7%
SUN PHARMACEUTICAL INDUSTRIES 1.6% -2.9% 17.2%
DIVIS LABORATORIES 1.5% 10.4% 51.9%
CIPLA 2.3% 1.9% 2.8%
TORRENT PHARMACEUTICALS 1.4% 1.3% 17%
DR REDDYS LABORATORIES 5.7% 14.1% 15.2%
MANKIND PHARMA 0.2% -2.4% 12.5%
ZYDUS LIFESCIENCES 5.1% 10.9% -4.4%
LUPIN 2% -2.2% 27.9%

VENUS REMEDIES Quarterly Revenues

Revenues
Q-o-Q

10.24 %

Y-o-Y

-0.10 %

Quarters Revenues % Change
Mar2025 ₹195 Cr
10.24
Dec2024 ₹177 Cr
5.62
Sep2024 ₹167 Cr
54.18
Jun2024 ₹109 Cr
-44.35
Mar2024 ₹195 Cr
36.08
Dec2023 ₹143 Cr
-14.49
Sep2023 ₹168 Cr
76.27
Jun2023 ₹95 Cr -

VENUS REMEDIES Quarterly Operating Profit

Operating Profit
Q-o-Q

57.95 %

Y-o-Y

48.87 %

Quarters Operating Profit % Change
Mar2025 ₹29 Cr
57.95
Dec2024 ₹18 Cr
273.93
Sep2024 ₹5 Cr
-56.39
Jun2024 ₹11 Cr
-42.20
Mar2024 ₹19 Cr
61.79
Dec2023 ₹12 Cr
-32.17
Sep2023 ₹18 Cr
70.67
Jun2023 ₹10 Cr -
Operating Margins
Q-o-Q

43.26 %

Y-o-Y

49.00 %

Quarters Operating Margin% % Change
Mar2025 14.87%
43.26
Dec2024 10.38%
254.27
Sep2024 2.93%
-71.75
Jun2024 10.37%
3.91
Mar2024 9.98%
18.95
Dec2023 8.39%
-20.70
Sep2023 10.58%
-3.20
Jun2023 10.93% -

VENUS REMEDIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

7.14 %

Y-o-Y

99.81 %

Quarters Profit After Tax % Change
Mar2025 ₹21 Cr
7.14
Dec2024 ₹20 Cr
458.40
Sep2024 ₹4 Cr
187.70
Jun2024 ₹1 Cr
-88.39
Mar2024 ₹11 Cr
53.43
Dec2023 ₹7 Cr
-31.09
Sep2023 ₹10 Cr
742.37
Jun2023 ₹1 Cr -
PAT Margins
Q-o-Q

-2.80 %

Y-o-Y

99.81 %

Quarters PAT Margin(%) % Change
Mar2025 10.77 %
-2.80
Dec2024 11.08 %
427.62
Sep2024 2.1 %
87.50
Jun2024 1.12 %
-79.22
Mar2024 5.39 %
12.76
Dec2023 4.78 %
-19.39
Sep2023 5.93 %
378.23
Jun2023 1.24 % -

VENUS REMEDIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

7.16 %

Y-o-Y

99.87 %

Quarters EPS % Change
Mar2025 ₹15.71
7.16
Dec2024 ₹14.66
457.41
Sep2024 ₹2.63
189.01
Jun2024 ₹0.91
-88.42
Mar2024 ₹7.86
53.52
Dec2023 ₹5.12
-31.09
Sep2023 ₹7.43
744.32
Jun2023 ₹0.88 -

You may also like the below Video Courses